- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00202033
Impact of Self-Monitoring Blood Glucose Frequency on Glycemic Control in Patients With Type 2 Diabetes
December 2, 2015 updated by: HealthPartners Institute
To determine if the frequency of blood glucose testing in patients with type 2 diabetes who are being treated with diet and exercise alone or diet and exercise plus oral agents will impact the HbA1c level.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
To determine the impact of SMBG frequency on blood glucose control in patients receiving systematic diabetes management education through Type 2 Diabetes BASICS at International Diabetes Center.
Study Type
Interventional
Enrollment (Actual)
150
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55416
- International Diabetes Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 79 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Type 2 diabetes
- Treatment with diet and exercise alone or with the addition of 1 or 2 oral agents
- Enrolled in Type 2 BASICS program
- A1c between 7.0 and 11%, inclusive
- Able to understand spoken English
Exclusion Criteria:
- Insulin therapy
- Unable/unwilling to perform SMBG
- Participating in another research study
- Currently performing SMBG >3 times/week
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1
self monitor blood glucose 3 times a day per usual diabetes class curriculum
|
Evaluate the impact of self monitoring blood glucose frequency on glycemic control in patients with type 2 diabetes.
|
Experimental: 2
only self monitor blood glucose when fasting
|
Evaluate the impact of self monitoring blood glucose frequency on glycemic control in patients with type 2 diabetes.
|
Experimental: 3
no self monitoring of blood glucose
|
Evaluate the impact of self monitoring blood glucose frequency on glycemic control in patients with type 2 diabetes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
HbA1c
Time Frame: 2 years
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
blood glucose testing frequency
Time Frame: 2 years
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Richard M Bergenstal, MD, Park Nicollet Institute/International Diabetes Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2004
Primary Completion (Actual)
May 1, 2009
Study Completion (Actual)
May 1, 2009
Study Registration Dates
First Submitted
September 12, 2005
First Submitted That Met QC Criteria
September 12, 2005
First Posted (Estimate)
September 20, 2005
Study Record Updates
Last Update Posted (Estimate)
December 3, 2015
Last Update Submitted That Met QC Criteria
December 2, 2015
Last Verified
April 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 01856-04-C
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 2 Diabetes
-
Antonio Di MauroCompletedType-2 DiabetesItaly
-
DiaMedica Therapeutics IncCompletedDiabetes Type 2Netherlands
-
RenJi HospitalUnknownType 2 Diabetes.China
-
University of Erlangen-Nürnberg Medical SchoolCompletedType 2-diabetesGermany
-
Chengdu Brilliant Pharmaceutical Co., Ltd.Not yet recruitingType 2 Diabetes Mellitus
-
Nanjing First Hospital, Nanjing Medical UniversityRecruitingType 2 Diabetes MellitusChina
-
Xiangya Hospital of Central South UniversityRecruitingType 2 Diabetes MellitusChina
-
University of Alabama at BirminghamCompletedType 2 Diabetes MellitusUnited States
-
Imperial College LondonAstraZeneca; Huma; North West London Collaboration of CCGs (NWL CCGs); Imperial...CompletedType 2 Diabetes MellitusUnited Kingdom
-
Universiti Sains MalaysiaCompleted
Clinical Trials on frequency of self monitoring blood glucose
-
Manchester University NHS Foundation TrustDexCom, Inc.CompletedDiabetes Mellitus, Type 1United Kingdom
-
Sutter HealthGE Healthcare; University of California, Davis; LifeScanCompletedDiabetes Mellitus, Type 2United States
-
Yuwen ZhangCompletedDiabetes Mellitus, Type 2China
-
Oregon Health and Science UniversityDexCom, Inc.RecruitingGestational DiabetesUnited States
-
The George Washington University Biostatistics...Eunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
-
University Hospital Inselspital, BerneRecruiting
-
Medical University of ViennaRecruitingPregnancy Complications | Blood Glucose | Gestational Diabetes | GDM | CgmAustria
-
University of California, IrvineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingHemodialysis | Diabete Mellitus | Continuous Glucose MonitoringUnited States
-
University of North Carolina, Chapel HillPatient-Centered Outcomes Research InstituteCompletedDIABETES MELLITUS, NONINSULIN-DEPENDENT, 2 (Disorder)United States
-
Institut für Diabetes-Technologie Forschungs- und...Ascensia Diabetes CareCompleted